Tuberculosis and Respiratory Diseases

Diagnosis and Treatment of latent tuberculosis infection in adults in South Korea: Kyung-Wook Jo, Young Soon Yoon, Hyung Woo Kim, Joong-Yub Kim, Young Ae Kang; Received August 19, 2024 Accepted September 30, 2024 Published online October 4, 2024; DOI: https://doi.org/10.4046/trd.2024.0122 [Accepted]; PDF

High-dose rifampicin for 3 months after culture conversion for drug-susceptible pulmonary tuberculosis: Nakwon Kwak, Joong-Yub Kim, Hyung-Jun Kim, Byoung-Soo Kwon, Jae Ho Lee, Jeongha Mok, Yong-Soo Kwon, Young Ae Kang, Youngmok Park, Ji Yeon Lee, Doosoo Jeon, Jung-Kyu Lee, Jeong Seong Yang, Jake Whang, Kyung Jong Kim, Young Ran Kim, Minkyoung Cheon, Jiwon Park, Seokyung Hahn, Jae-Joon Yim; Received July 12, 2024 Accepted September 25, 2024 Published online September 27, 2024; DOI: https://doi.org/10.4046/trd.2024.0099 [Accepted]; PDF

Regenerative capacity of alveolar type 2 cells is proportionally reduced following disease progression in idiopathic pulmonary fibrosis-derived organoid cultures: Hyeon Kyu Choi, Gaeul Bang, Ju Hye Shin, Mi Hwa Shin, Ara Woo, Song Yee Kim, Sang Hoon Lee, Eun Young Kim, Hyo Sup Shim, Young Joo Suh, Ha Eun Kim, Jin Gu Lee, Jinwook Choi, Ju Hyeon Lee, Chul Hoon Kim, Moo Suk Park; Received July 4, 2024 Accepted September 22, 2024 Published online September 27, 2024; DOI: https://doi.org/10.4046/trd.2024.0094 [Accepted]; PDF

Diagnostic Accuracy of BD MAX MDR-TB Assay Performed on Bronchoscopy Specimens in Patients with Suspected Pulmonary Tuberculosis: Sung Jun Ko, Kui Hyun Yoon; Received July 27, 2024 Accepted September 14, 2024 Published online September 23, 2024; DOI: https://doi.org/10.4046/trd.2024.0091 [Accepted]; PDF

KEAP1-NRF2 pathway as a novel therapeutic target for EGFR-mutant non-small cell lung cancer: Jae-Sun Choi, Hye-Min Kang, Kiyong Na, Jiwon Kim, Tae-Woo Kim, Junyang Jung, Heejin Lim, Hyewon Seo, Seung Hyeun Lee; Received July 20, 2024 Accepted September 11, 2024 Published online September 23, 2024; DOI: https://doi.org/10.4046/trd.2024.0087 [Accepted]; PDF

Clinical profiles of multidrug-resistant and rifampicin-monoresistant tuberculosis in Korea, 2018-2021: a nationwide cross-sectional study: Jinsoo Min, Yousang Ko, Hyung Woo Kim, Hyeon-Kyoung Koo, Jee Youn Oh, Doosoo Jeon, Taehoon Lee, Young-Chul Kim, Sung Chul Lim, Sung Soon Lee, Jae Seuk Park, Ju Sang Kim; Received April 4, 2024 Accepted September 20, 2024 Published online September 23, 2024; DOI: https://doi.org/10.4046/trd.2024.0049 [Accepted]; PDF

Beyond the Spirometry: New Diagnostic Modalities in COPD: Jin Hwa Song, Youlim Kim; Received March 22, 2024 Accepted September 19, 2024 Published online September 23, 2024; DOI: https://doi.org/10.4046/trd.2024.0040 [Accepted]; PDF

35,770	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
6,233	Proposed Etiotypes for Chronic Obstructive Pulmonary Disease: Controversial Issues
6,613	Tuberculosis: Republic of Korea, 2021
12,563	Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
2,004	Effects of the Use of Beta-Blockers on Chronic Obstructive Pulmonary Disease Associated with Cardiovascular Comorbities: Systematic Review and Meta-analysis

Cited By 32	Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
Cited By 22	Tuberculosis: Republic of Korea, 2021
Cited By 15	Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
Cited By 12	Pulmonary Functions and Inflammatory Biomarkers in Post-Pulmonary Tuberculosis Sequelae
Cited By 12	Long-Term Outcome of Chronic Obstructive Pulmonary Disease: A Review

Accepted articles